See more : Gen Digital Inc. (GEN) Income Statement Analysis – Financial Results
Complete financial analysis of Neuromeka Co., Ltd. (348340.KQ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Neuromeka Co., Ltd., a leading company in the industry within the sector.
- CellSeed Inc. (7776.T) Income Statement Analysis – Financial Results
- Sprout AI Inc. (BYFM.CN) Income Statement Analysis – Financial Results
- DHT Holdings, Inc. (DHT) Income Statement Analysis – Financial Results
- Shuka Minerals Plc (SKA.L) Income Statement Analysis – Financial Results
- Virios Therapeutics, Inc. (VIRI) Income Statement Analysis – Financial Results
Neuromeka Co., Ltd. (348340.KQ)
Website: https://www.neuromeka.com
About Neuromeka Co., Ltd.
Neuromeka Co.,Ltd. manufactures industrial robots. It builds a Robot as a Service platform business ecosystem centered on collaborative robots. The company offers collaborative, co-industrial, mobile, and delta robots; smart actuators, robot controllers, teach pendants, and vision solutions, as well as robot software; standard tools; and robot platform and remote management services. It serves the manufacturing, f&b service, and media and art applications. The company was founded in 2013 and is based in Seoul, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 13.74B | 9.75B | 7.35B | 4.07B | 7.21B |
| Cost of Revenue | 12.52B | 8.60B | 5.51B | 3.82B | 5.79B |
| Gross Profit | 1.22B | 1.15B | 1.84B | 247.89M | 1.42B |
| Gross Profit Ratio | 8.89% | 11.81% | 24.99% | 6.10% | 19.74% |
| Research & Development | 5.26B | 1.92B | 931.67M | 3.82B | 2.65B |
| General & Administrative | 1.23B | 481.39M | 333.97M | 193.65M | 72.96M |
| Selling & Marketing | 1.67B | 2.57B | 622.54M | 691.69M | 1.04B |
| SG&A | 2.90B | 3.05B | 956.51M | 885.34M | 3.40B |
| Other Expenses | 7.89B | 182.23M | 110.47M | 803.13M | 0.00 |
| Operating Expenses | 16.05B | 8.94B | 4.85B | 8.40B | 1.11B |
| Cost & Expenses | 28.57B | 17.55B | 10.36B | 12.22B | 6.90B |
| Interest Income | 1.10B | 315.70M | 57.40M | 52.64M | 3.30B |
| Interest Expense | 2.05B | 292.00M | 532.95M | 481.31M | 3.38B |
| Depreciation & Amortization | 1.01B | 901.29M | 888.92M | 975.59M | 646.89M |
| EBITDA | -14.59B | -6.91B | -1.84B | -6.81B | -4.56B |
| EBITDA Ratio | -106.16% | -64.86% | -24.99% | -158.06% | -63.19% |
| Operating Income | -14.83B | -7.80B | -3.01B | -8.15B | -5.20B |
| Operating Income Ratio | -107.88% | -79.94% | -40.93% | -200.57% | -72.16% |
| Total Other Income/Expenses | -2.82B | -402.47M | -3.59B | -116.56M | 2.21B |
| Income Before Tax | -17.65B | -8.20B | -6.59B | -8.27B | -2.99B |
| Income Before Tax Ratio | -128.40% | -84.07% | -89.70% | -203.43% | -41.49% |
| Income Tax Expense | 7.10M | 570.20M | 283.07M | 752.77M | 0.00 |
| Net Income | -17.65B | -8.20B | -6.59B | -8.27B | -2.99B |
| Net Income Ratio | -128.45% | -84.07% | -89.70% | -203.43% | -41.49% |
| EPS | -1.69K | -953.00 | -4.58K | -6.21K | -2.25K |
| EPS Diluted | -1.69K | -953.00 | -4.58K | -6.21K | -2.25K |
| Weighted Avg Shares Out | 10.42M | 8.61M | 1.44M | 1.33M | 1.33M |
| Weighted Avg Shares Out (Dil) | 10.42M | 8.61M | 1.44M | 1.33M | 1.33M |
Source: https://incomestatements.info
Category: Stock Reports